Recurrence and outcome in skull base meningiomas: Do they differ from other intracranial meningiomas?

Skull Base

Volumn 18, Issue 4, 2008, Pages 243-252

  Nanda, Anil ^a   Vannemreddy, Prasad ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

Convexity; Meningioma; Outcome; Recurrence; Skull base

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MICROSURGERY; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT CANCER; SKULL BASE TUMOR; TREATMENT RESPONSE; TUMOR LOCALIZATION;

EID: 52949107997     PISSN: 15315010     EISSN: 15320065     Source Type: Journal    
DOI: 10.1055/s-2007-1016956     Document Type: Article

References (32)

1. Cushing H, Eisenhardt L. Meningiomas: their classification, regional behavior, life history, and surgical end results. In: Zülch KJ, ed. Brain Tumors: Their Biology and Pathology. New York: Springer-Verlag; 1986:380-383
2. Lefkowitz MA, Hinton DR, Weiss MH, Giannotta SL, Couldwell WT. Prognostic variables in surgery for skull base meningiomas. Neurosurg Focus 1997;2:e2
3. Nakamura M, Samii M. Surgical management of a meningioma in the retrosellar region. Acta Neurochir (Wien) 2003;145:215-219
4. McCarthy BJ, Davis FG, Freels S, et al. Factors associated with survival in patients with meningioma. J Neurosurg 1998;88:831-839
5. Torp SH, Lindboe CF, Grønberg BH, Lydersen S, Sundstrøm S. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas. Clin Neuropathol 2005;24:170-174
6. Roser F, Samii M, Ostertag H, Bellinzona M. The Ki-67 proliferation antigen in meningiomas: experience in 600 cases. Acta Neurochir (Wien) 2004;146:37-44; discussion 44
7. Yamashita J, Handa H, Iwaki K, Abe M. Recurrence of intracranial meningiomas, with special reference to radiotherapy. Surg Neurol 1980;14:33-40
8. Louis DN, Sheithauer BW, Budka H, Von Deimling A, Kepes JJ. Meningiomas. In: Kluihues P, Cavenee WK, eds. Pathology and Genetics of Tumors of the Nervous System. Lyon, France: IARC Press; 2000:176-189
9. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985;62:18-24
10. Christensen D, Laursen H, Klinken L. Prediction of recurrence in meningiomas after surgical treatment: a quantitative approach. Acta Neuropathol 1993;61:130-134
11. Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Strangeby C, Husain M. Malignant progression in meningioma: documentation of a series and analysis of cytogenic findings. J Neurosurg 2004;101:210-218
12. Simpson D. The recurrence of meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20:22-39
13. Adegbite AB, Khan MI, Paine KW, Tan LK. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 1983;58:51-56
14. Borovich B, Doron Y. Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg 1986;64:58-63
15. Borovich B, Doron Y, Braun J, et al. Recurrence of intracranial meningiomas: the role played by multicentricity. Part 2: clinical and radiological aspects. J Neurosurg 1986;65:168-171
16. Jääskeläinen J, Haltia M, Laasonen E, Wahlström T, Valtonen S. The growth rate of intracranial meningiomas and its relation to histology: an analysis of 43 patients. Surg Neurol 1985;24:165-172
17. Mahmood A, Quereshi NH, Malik GM. Intracranial meningiomas: analysis of recurrence after surgical treatment. Acta Neurochir (Wien) 1994;126:53-58
18. Mathiesen T, Lindquest C, Kihlstyrom L, Karlsson B. Recurrence of cranial base menigiomas. Neurosurgery 1996; 39:2-7
19. De Jesus O, Sekhar LN, Parikh HK, et al. Long-term follow-up of patients with meningiomas involving the cavernous sinus: recurrence, progression and quality of life. Neurosurgery 1996;39:915-920
20. Couldwell WT, Fukushima T, Gionnotta SL, et al. Petroclival meningiomas: surgical experience in 109 cases. J Neurosurg 1996;84:20-28
21. DeMonte F, Smith HK, Al-Mefty O. Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg 1994;81:245-251
22. Kinjo T, Al-Mefty O, Kanaan I. Grade zero removal of supratentorial convexity meningiomas. Neurosurgery 1993; 33:394-399
23. Kajiwara K, Fudaba H, Tsuha M, et al. Analysis of recurrences of meningiomas following neurosurgical resection [in Japanese, English abstract]. No Shinkei Geka 1989;17:1125-1131
24. Waga S, Yamashita J, Handa H. Recurrence of meningiomas [in Japanese, English abstract]. Neurol Med Chir (Tokyo) 1977;17:203-208
25. Ayerbe J, Lobato RD, de la Cruz J, et al. Risk factors predicting recurrence in patients operated on for intracranial meningioma: a multivariate analysis. Acta Neurochir (Wien) 1999;141:921-932
26. Tao W, Zhimin W, Xianhaou Y, Weiguo C. Multivariate analysis of recurrence in meningioma. The Chinese-German Journal of Clinical Oncology 2005;4:26-29
27. Nakasu S, Nakajima M, Matsumura KI, Nakasu Y, Handa J. Meningioma: proliferating potential and clinico-radiological features. Neurosurgery 1995;37:1049-1055
28. Langford LA, Cooksley CS, DeMonte F. Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol 1996;27:350-354
29. Prayson RA. Malignant meningioma: a clinicopathologic study of 23 patients including MIB-1 and p53 immunohistochemistry. Am J Clin Pathol 1996;105:719-726
30. Lanzafame S, Torrisi A, Barbagallo G, et al. Corrrelation between histological grade, MIB-1, and recurrence in 69 completely resected primary intracranial meningiomas with a 6-year mean follow-up. Pathol Res Pract 2000;196: 483-488
31. Vannemreddy P, Nanda A, Fowler M, Nordberg ML. Skull Base Meningiomas: Do They Have a Higher Proliferation Potential for Aggression? Paper presented at: North American Skull Base Society Annual Meeting; February 16-19, 2006; Phoenix, AZ
32. Wigertz A, Lonn S, Mathiesen T, Ahlbom A, Hall P, Feychting M, Swedish Interphone Study Group. Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 2006;164:629-636